Norden Group »

Regeneron Pharmaceuticals shares owned by Norden Group

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Norden Group from 13F filings

Historical chart of Norden Group investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Norden Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Norden Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $373k 388 962.33
2023-12-31 $230k 262 878.29

More positions owned by Norden Group

Microsoft Corporation (MSFT)
Amazon (AMZN)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Apple (AAPL)
Spdr Ser Tr Bloomberg High Y (JNK)
NVIDIA Corporation (NVDA)
Ishares Tr U.s. Finls Etf (IYF)
Ishares Tr Us Industrials (IYJ)
Ishares Tr Us Consum Discre (IYC)
Ishares Tr U.s. Tech Etf (IYW)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Netflix (NFLX)

View all positions for Norden Group

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Susquehanna International
Ubs Global Asset Management Americas
Charles Schwab Investment Management

View all funds holding Regeneron Pharmaceuticals